Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("LEONARD, R. C. F")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 104

  • Page / 5
Export

Selection :

  • and

High dose chemotherapy for breast cancer : the case for trials in adjuvant therapyLEONARD, R. C. F.Journal of the Royal Society of Medicine. 1996, Vol 89, Num 6, pp 337P-339P, issn 0141-0768Article

Tumor markers of prognosisLEONARD, R. C. F.Journal of clinical oncology. 1991, Vol 9, Num 7, pp 1102-1104, issn 0732-183XArticle

Oral fluoropyrimidines among the new drugs for patients with metastatic breast cancerLEONARD, R. C. F.British journal of cancer. 2001, Vol 84, Num 11, pp 1437-1442, issn 0007-0920Article

High dose therapy of breast cancer : current statusDAWSON, L. K; LEONARD, R. C. F.Critical reviews in oncology/hematology. 1999, Vol 30, Num 1, pp 35-43, issn 1040-8428Article

Adverse effects of cancer chemotherapy : an overview of techniques for avoidance/minimisationNICOLSON, M; LEONARD, R. C. F.Drug safety. 1992, Vol 7, Num 5, pp 316-322, issn 0114-5916Article

Anti-emetics and cancer chemotherapyLEONARD, R. C. F; SOUKOP, M.British journal of cancer. 1990, Vol 61, Num 3, pp 349-350, issn 0007-0920, 2 p.Article

The heterogeneity of human cancers and its influence on metastases and therapyLEONARD, R. C. F; SMYTH, J. F.European journal of cancer & clinical oncology. 1985, Vol 21, Num 9, pp 1001-1004, issn 0277-5379Article

Miltefosine in recurrent cutaneous breast cancerCLIVE, S; LEONARD, R. C. F.Lancet (British edition). 1997, Vol 349, Num 9052, pp 621-622, issn 0140-6736Article

The advancement of high-dose chemotherapy and dose intensification schedulesLEONARD, R. C. F.Annals of oncology. 1997, Vol 8, pp S3-S6, issn 0923-7534, SUP3Conference Paper

The case for high-dose adjuvant chemotherapy in breast cancer : (II) clinical experienceCAMERON, D. A; LEONARD, R. C. F.European journal of surgical oncology. 1996, Vol 22, Num 6, pp 634-637, issn 0748-7983Article

Expression of human milk fat globule antigens HMFG1 and HMFG2 on ovarian tumours and lung tumoursHAY, F. G; LEONARD, R. C. F.Disease markers. 1988, Vol 6, Num 1, pp 29-39, issn 0278-0240Article

Type 1 growth factor receptor expression in node positive breast cancer: adverse prognostic significance of c-erbB-4LODGE, A. J; ANDERSON, J. J; GULLICK, W. J et al.Journal of clinical pathology. 2003, Vol 56, Num 4, pp 300-304, issn 0021-9746, 5 p.Article

Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancerGABRA, H; CAMERON, D. A; LEE, L. E et al.British journal of cancer. 1996, Vol 74, Num 12, pp 2008-2012, issn 0007-0920Article

Sensitive determination of 8-chloroadenosine 3',5'-monophosphate and 8-chloroadenosine in plasma by high-performance liquid chromatographyCUMMINGS, J; LEONARD, R. C. F; MILLER, W. R et al.Journal of chromatography. Biomedical applications. 1994, Vol 658, Num 1, pp 183-188, issn 0378-4347Article

Infusional 5-fluorouracil in breast cancerNG, J. S. Y; CAMERON, D. A; LEONARD, R. C. F et al.Cancer treatment reviews. 1994, Vol 20, Num 4, pp 357-364, issn 0305-7372Article

An assessment of the clinical usefulness of two serum markers, CA 15 3 and HMFG 2 in localized and metastatic breast cancerBLISS, P; FISKEN, J; ROULSTEN, J et al.Disease markers. 1993, Vol 11, Num 1, pp 45-48, issn 0278-0240Article

Serological markers for metastatic breast cancerNG, J. S. Y; STURGEON, C. M; SETH, J et al.Disease markers. 1993, Vol 11, Num 5-6, pp 217-223, issn 0278-0240Article

Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinomaECCLES, D. M; BRETT, L; LESSELLS, A et al.British journal of cancer. 1992, Vol 65, Num 1, pp 40-44, issn 0007-0920Article

Immunocytological detection of residual marrow disease at clinical remission predicts metastatic relapse in small cell lung cancerLEONARD, R. C. F; DUNCAN, L. W; HAY, F. G et al.Cancer research (Baltimore). 1990, Vol 50, Num 20, pp 6545-6548, issn 0008-5472, 4 p.Article

Bowel obstruction in ovarian carcinoma: a restrospective study and review of the literatureBEATTIE, G. J; LEONARD, R. C. F; SMYTH, J. F et al.Palliative medicine. 1989, Vol 3, Num 4, pp 275-280, issn 0269-2163, 6 p.Article

Phase I study of TCNU, a novel nitrosoureaSMYTH, J. F; MACPHERSON, J. S; WARRINGTON, P. S et al.European journal of cancer & clinical oncology. 1987, Vol 23, Num 12, pp 1845-1849, issn 0277-5379Article

Continuous 5-fluorouracil in the treatment of breast cancerCAMERON, D. A; GABRA, H; LEONARD, R. C. F et al.British journal of cancer. 1994, Vol 70, Num 1, pp 120-124, issn 0007-0920Article

Treatment options for older woman with early breast cancerMYAT MOE, M; PWINT, T. Pwint; LEONARD, R. C. F et al.Expert review of anticancer therapy. 2006, Vol 6, Num 6, pp 941-950, issn 1473-7140, 10 p.Article

A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphomaHAYWARD, R. L; LEONARD, R. C. F; PRESCOTT, R. J et al.British journal of cancer. 1991, Vol 63, Num 6, pp 945-952, issn 0007-0920, 8 p.Article

Immunoassay of CA125 in ovarian cancer: a comparison of three assays for use in diagnosis and monitoringFISKEN, J; LEONARD, R. C. F; ROULSTON, J. E et al.Disease markers. 1989, Vol 7, Num 1, pp 61-67, issn 0278-0240, 7 p.Article

  • Page / 5